| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 413.424 | 401.622 | 453.019 | 521.578 | 538.837 | 614.612 | 689.511 | 836.287 | 892.461 | 935.468 |
| Total Income - EUR | 451.734 | 442.434 | 526.354 | 544.021 | 559.115 | 636.826 | 712.142 | 882.786 | 908.196 | 967.386 |
| Total Expenses - EUR | 422.428 | 410.652 | 475.598 | 510.572 | 525.094 | 574.409 | 659.735 | 781.041 | 843.765 | 912.025 |
| Gross Profit/Loss - EUR | 29.307 | 31.782 | 50.756 | 33.449 | 34.021 | 62.418 | 52.407 | 101.745 | 64.431 | 55.360 |
| Net Profit/Loss - EUR | 22.978 | 25.793 | 45.402 | 27.490 | 28.182 | 56.509 | 45.467 | 93.046 | 52.476 | 41.694 |
| Employees | 6 | 6 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 |
Check the financial reports for the company - Alfamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.463 | 24.389 | 23.175 | 23.370 | 21.595 | 20.692 | 19.164 | 18.417 | 17.568 | 16.682 |
| Current Assets | 139.912 | 149.807 | 214.709 | 233.804 | 252.525 | 283.069 | 346.599 | 400.477 | 404.931 | 321.993 |
| Inventories | 112.850 | 125.132 | 166.604 | 162.201 | 168.069 | 184.049 | 178.056 | 210.349 | 225.302 | 197.526 |
| Receivables | 25.129 | 12.780 | 43.685 | 62.875 | 52.718 | 68.179 | 94.824 | 103.518 | 124.980 | 101.298 |
| Cash | 1.932 | 11.896 | 4.420 | 8.728 | 31.738 | 30.840 | 73.719 | 86.610 | 54.649 | 23.169 |
| Shareholders Funds | 24.190 | 26.993 | 46.581 | 28.648 | 29.317 | 57.622 | 46.556 | 93.620 | 53.048 | 44.188 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 141.185 | 147.204 | 191.303 | 228.525 | 244.802 | 246.139 | 319.206 | 325.273 | 369.451 | 294.487 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Alfamed S.r.l.